NEAT1 as a Diagnostic Biomarker and Therapeutic Target for Alzheimer's Disease: A Comprehensive Review.

Zamanian MY, Belaia OF, Gardanova ZR

Open source

DOI
10.2174/0118715273431267260210124040
Published
2026 Mar 26
Container
CNS & neurological disorders drug targets
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2174/0118715273431267260210124040,
  title = {NEAT1 as a Diagnostic Biomarker and Therapeutic Target for Alzheimer's Disease: A Comprehensive Review.},
  author = {Zamanian MY and Belaia OF and Gardanova ZR},
  year = {2026},
  journal = {CNS \& neurological disorders drug targets},
  doi = {10.2174/0118715273431267260210124040},
  url = {https://doi.org/10.2174/0118715273431267260210124040}
}

RIS

TY  - JOUR
TI  - NEAT1 as a Diagnostic Biomarker and Therapeutic Target for Alzheimer's Disease: A Comprehensive Review.
AU  - Zamanian MY
AU  - Belaia OF
AU  - Gardanova ZR
PY  - 2026
JO  - CNS & neurological disorders drug targets
DO  - 10.2174/0118715273431267260210124040
UR  - https://doi.org/10.2174/0118715273431267260210124040
ER  - 

APA

MY, Z., OF, B., & ZR, G. (2026). NEAT1 as a Diagnostic Biomarker and Therapeutic Target for Alzheimer's Disease: A Comprehensive Review.. CNS & neurological disorders drug targets. https://doi.org/10.2174/0118715273431267260210124040

Source records